Kepler Cheuvreux’s Quest Diagnostics DGX Stock Holding History

Kepler Cheuvreux’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.2M	Buy	+9,438	New	+$2.18M	0.13%	88

Other funds holding DGX

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Midwest Trust Overland Park, Kansas $8.99B AUM 21.14% 1-Year Est. Return

Kepler Cheuvreux's DGX Position: Q3 2026 in Review

Kepler Cheuvreux opened a new position in Quest Diagnostics (DGX) in Q3 2026: 9,438 shares worth $2.2M. The stake represents 0.13% of the portfolio and ranks #88 among its holdings.

231 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Kepler Cheuvreux held 9,438 shares of Quest Diagnostics worth $2.2M as of Q3 2026.
Quest Diagnostics was a new Kepler Cheuvreux position in Q3 2026.
Quest Diagnostics made up 0.13% of Kepler Cheuvreux's portfolio in Q3 2026, its #88 holding.
231 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Kepler Cheuvreux's 13F filing for Q3 2026, filed 20 Oct 2026.